Skip to content

International

Attending the RICT2024 in Bordeaux

Akane Kawamura, Siddique Amin and Filomena Saulino attended the RICT2024 (the 58th International Conference on Medicinal Chemistry) held in Bordeaux this July – a conference focused on the intersection of chemical biology and drug discovery.  Akane Kawamura gave a talk on cyclic peptides as chemical tools to probe biology, and our PhD Students presented their posters relating to work on cyclic peptides (Siddique), and inhibitor development against epigenetic reader domains (Filomena).   The event was a fantastic experience, with plenty of discussions with other medicinal chemists and chemical biologists from around the globe.  

International Women’s Day 2024

Friday 8th March 2024 marked International Women’s Day, which is a time to celebrate the contributions of women in various fields, including scientific research and chemical biology. Female scientists have been led ground-breaking research, contributing to our understanding of complex biological systems and the development of innovative medical treatments and drug discovery.  International Women’s Day also reinforces the importance of supporting and encouraging women in science to ensure a diverse and inclusive future for all scientific endeavours.    Emma Wadworth (PhD Student):  “To any young women, from any background, thinking of a career in science, definitely push yourself! Working towards new scientific discoveries is a challenging and rewarding experience.”   … Read More »International Women’s Day 2024

Down Under at the International Peptide Symposium

Prof Akane Kawamura travelled down under in October 2023 to talk about peptide probes for studying epigenetic proteins at the 13th International Peptide Symposium in Brisbane Australia.   A special thanks to the organisers for this great opportunity to meet with peptide and protein chemists, old friends and collaborators, and many new faces.   

Tom Visits Novo Nordisk in Denmark

Written by: Tom Smith. From October to December 2022, I had the privilege of visiting the R&D site of Novo Nordisk in Denmark as part of the Kawamura Group’s ongoing collaboration with this pharmaceutical company. It was incredible to experience the cutting-edge science going on there; the company specialises in treating diabetes as well as a variety of other chronic illnesses, and the wealth of expertise they have onsite in peptide chemistry and many other areas was fantastic to be part of. During my placement I was able to undertake various projects including massively parallel peptide synthesis, high throughput screening assays, and DNA library sequencing analysis. As well as improving… Read More »Tom Visits Novo Nordisk in Denmark